How to Evaluate Telehealth for Low Testosterone

What Low Testosterone Actually Means Clinically

Low testosterone, or hypogonadism, is not a diagnosis a provider should hand out based on symptoms alone. The 2018 American Urological Association guideline states directly: "Testosterone deficiency should be diagnosed only in the setting of consistent symptoms and signs, confirmed by accurate and reliable laboratory testing." A single low number on a single blood draw is not sufficient.

The Two-Draw Rule

The AUA 2018 guideline requires two separate measurements of serum total testosterone, both collected in the morning (between 7 a.m. And 10 a.m. When levels peak), on different days, in a fasting or minimally fasted state. Values below 300 ng/dL on both draws define biochemical hypogonadism. Some men have borderline values between 300 and 400 ng/dL, and in those cases free testosterone or calculated free testosterone adds diagnostic clarity, especially in men with elevated sex-hormone-binding globulin (SHBG).

Why Morning Timing Matters

Total testosterone follows a circadian rhythm. A draw taken at 3 p.m. Can read 15-25% lower than the same man's 8 a.m. Value. Telehealth platforms that allow afternoon blood draws, or that use finger-stick at-home kits as the sole diagnostic specimen, introduce measurement error that could lead to either overdiagnosis or underdiagnosis. A 2021 analysis in the Journal of Clinical Endocrinology and Metabolism (JCEM) confirmed that afternoon testosterone values were diagnostically unreliable in up to 30% of men tested, compared with matched morning samples [1].

Symptoms That Support the Diagnosis

Biochemical confirmation is necessary but not sufficient on its own. The Endocrine Society's 2018 clinical practice guideline on male hypogonadism lists the following as cardinal symptoms: decreased libido, erectile dysfunction, reduced spontaneous erections, loss of body or facial hair, hot flashes, reduced energy, depressed mood, decreased lean muscle mass, and increased body fat [2]. A quality telehealth intake should document at least three of these symptoms before treatment is initiated.

The Minimum Lab Panel a Quality Telehealth Platform Should Order

A bare-bones "testosterone only" panel is a warning sign. Testosterone does not exist in isolation; it converts to estradiol, it suppresses LH and FSH, and it raises hematocrit. Any platform that skips the supporting labs is flying blind.

Baseline Labs: The Non-Negotiables

The following labs should appear on your baseline requisition from any reputable telehealth TRT provider:

• Total testosterone (two morning draws, as above)
• Free testosterone (direct or calculated via SHBG)
• SHBG (sex hormone-binding globulin)
• LH and FSH (to distinguish primary from secondary hypogonadism)
• Estradiol (sensitive or ultrasensitive assay, not standard immunoassay)
• PSA (prostate-specific antigen, for men 40 and older, or 35 and older in high-risk groups per AUA guidelines)
• CBC with hematocrit (TRT raises red blood cell mass; hematocrit above 54% is a dose-reduction or hold criterion)
• Comprehensive metabolic panel (CMP, for liver function if oral or buccal testosterone is considered)
• Prolactin (to rule out hyperprolactinemia as a secondary cause)

Why LH and FSH Change Your Treatment

If your LH and FSH are high alongside a low testosterone, you have primary hypogonadism: the testes are failing despite adequate stimulation. If LH and FSH are low or normal with low testosterone, the problem is hypothalamic or pituitary in origin (secondary hypogonadism). This distinction matters because secondary hypogonadism in a young man may be treatable with clomiphene citrate or gonadorelin rather than exogenous testosterone, preserving fertility entirely. A telehealth provider who never orders LH and FSH cannot make this distinction.

Monitoring Labs After Starting TRT

The Endocrine Society 2018 guideline recommends monitoring total testosterone, hematocrit, and PSA at 3-6 months after starting therapy, then annually once stable [2]. Estradiol should be checked at 3 months because aromatase activity varies; men with higher body fat convert more testosterone to estradiol, and symptoms of high estradiol (water retention, mood instability, reduced libido) overlap with low testosterone symptoms. Missing this follow-up loop is where many low-cost telehealth models cut corners.

How to Evaluate the Prescribing Physician's Credentials and Protocol

The physician (or nurse practitioner, or PA) signing your TRT prescription should be identifiable, licensed in your state, and reachable. Telehealth platforms are regulated by state medical boards, and the prescribing clinician must be licensed in the state where you physically reside at the time of your consultation.

Confirming Licensure

Every state medical board maintains a public license-verification portal. Before you pay for a consultation, search the prescribing clinician's name on your state's medical board website. A license in good standing, with no disciplinary actions, takes two minutes to confirm. If the platform obscures the prescribing clinician's identity or lists only a company name, that is a meaningful compliance concern.

What a Good Intake Consultation Looks Like

A thorough telehealth intake for TRT should take 20-40 minutes. The clinician should ask about:

• Duration and severity of symptoms
• Prior lab history and any prior testosterone therapy
• Cardiovascular history (TRT is used cautiously after major adverse cardiovascular events; the FDA added a label warning in 2015 [3])
• Medications that affect testosterone metabolism (opioids, glucocorticoids, ketoconazole)
• Fertility goals (exogenous testosterone suppresses spermatogenesis within 4-6 weeks)
• Testicular trauma, mumps orchitis, or prior chemotherapy or radiation history
• Sleep apnea screening (TRT may worsen obstructive sleep apnea)

If your consultation lasts under 10 minutes and skips most of these questions, the protocol is inadequate regardless of the prescription cost.

Controlled Substance Prescribing Rules

Testosterone is a Schedule III controlled substance under the Controlled Substances Act [4]. Federal law and the Ryan Haight Online Pharmacy Consumer Protection Act historically required an in-person evaluation before a controlled substance could be prescribed via telemedicine. The DEA issued temporary COVID-era flexibilities in 2020 that allowed initial prescribing via telemedicine; those flexibilities expired in 2025. Confirm with any telehealth provider what their current prescribing pathway is, including whether a referral to an in-person visit may be required before your first prescription is filled.

Delivery Methods Offered and What They Signal About Clinical Quality

TRT is not one-size-fits-all. Different delivery routes produce different pharmacokinetic profiles, and a quality provider should explain the trade-offs rather than defaulting to the cheapest or easiest option.

Testosterone Cypionate and Enanthate Injections

Weekly or biweekly subcutaneous or intramuscular injections of testosterone cypionate (typically 100-200 mg/week) are the most studied formulation in outpatient TRT. They produce predictable peaks and troughs, and dose adjustments are straightforward. The T-Trials (Testosterone Trials), a consortium of seven placebo-controlled studies in men 65 and older with confirmed hypogonadism, used testosterone gel but established the general principle that testosterone therapy in symptomatic hypogonadal men improves sexual function, mood, and bone mineral density [5].

Transdermal Gels and Creams

Gels (Androgel 1.62%, Testim, Vogelxo) are applied daily to skin and produce stable serum levels without injection peaks. Transfer to female partners or children through skin contact is a real risk; the FDA issued a black-box warning on gel products specifically for this reason [3]. Telehealth platforms should counsel on application site rotation and hand-washing as part of every gel prescription.

Pellets, Patches, and Oral Options

Subcutaneous pellets (Testopel) require an in-office procedure every 3-6 months and cannot be dose-adjusted once implanted. That rigidity makes them a poor first-line choice for new patients whose optimal dose is unknown. Patches (Androderm) are less popular due to skin irritation rates of 40-60% in clinical use. Oral testosterone undecanoate (Jatenzo, Tlando) is FDA-approved but requires twice-daily dosing with meals and carries a blood pressure warning [6]. Any telehealth platform that recommends pellets as a starting option without explaining the inability to adjust dose is prioritizing margin over medicine.

Fertility Preservation: A Conversation Many Platforms Skip

Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal (HPG) axis. LH and FSH drop within weeks, and sperm production falls dramatically. Studies show that azoospermia (zero sperm count) develops in roughly 40% of men on TRT within 6 months [7]. Recovery after stopping TRT varies widely; a 2015 meta-analysis in JAMA (N=1,549) found that 67% of men recovered baseline sperm counts within 12 months of stopping, but 10% had not recovered at 24 months [8].

HCG Co-Prescription

Human chorionic gonadotropin (HCG) mimics LH and maintains intratesticular testosterone and spermatogenesis during TRT. A typical protocol uses 500-1,000 IU of HCG subcutaneously two to three times per week alongside testosterone. Any telehealth platform treating men under 40 should raise fertility preservation proactively, not only if the patient asks.

Clomiphene as an Alternative

For men with secondary hypogonadism who want to preserve fertility, clomiphene citrate (25-50 mg every other day or daily) can raise endogenous testosterone by 100-200 ng/dL while maintaining or improving sperm parameters. Several prospective trials have confirmed this effect, including a 2019 study in Fertility and Sterility (N=86) showing clomiphene raised mean total testosterone from 248 ng/dL to 461 ng/dL over 12 weeks without suppressing sperm counts [9].

Red Flags That Should Rule Out a Platform

Some behaviors are disqualifying regardless of price or convenience.

Prescribing Without Confirmed Labs

Any platform that offers to prescribe testosterone based on symptoms alone, or based on a single unconfirmed lab value, is not practicing within guideline standards. This is the single most common shortcut in the direct-to-consumer TRT space.

No Follow-Up Protocol

TRT without scheduled monitoring is medically incomplete. Hematocrit elevation is the most common serious adverse effect; polycythemia raises thrombosis risk and can progress silently. The FDA label for all testosterone products requires hematocrit monitoring [3]. Platforms that issue a 3-month supply with no follow-up visit or lab order scheduled should not be used.

No Discussion of Cardiovascular Risk

The cardiovascular safety of TRT was examined in the TRAVERSE trial, published in NEJM in 2023 (N=5,246, median follow-up 33 months). TRT in men with hypogonadism and high cardiovascular risk did not increase major adverse cardiovascular events versus placebo (hazard ratio 0.96, 95% CI 0.78-1.17) [10]. That finding is reassuring, but the TRAVERSE trial also found higher rates of atrial fibrillation (3.5% vs. 2.4%), pulmonary embolism (0.9% vs. 0.5%), and acute kidney injury in the testosterone arm. A quality provider discusses this data, not ignores it.

Selling Supplements Alongside the Prescription

Platforms that bundle their prescription with proprietary supplements, especially those claiming to "support" testosterone, are generating margin from upsell rather than clinical value. Zinc, vitamin D, and ashwagandha have modest data at best; none replace evidence-based TRT in confirmed hypogonadism.

Pricing, Transparency, and What You Should Expect to Pay

Telehealth TRT pricing varies from roughly $75 per month to over $400 per month depending on formulation, lab fees, and platform structure. Testosterone cypionate generic is inexpensive (often $30-60 per month at compounding pharmacies). The cost differential usually reflects lab frequency, physician access, and whether HCG or anastrozole is included.

Questions to Ask Before Paying

Ask every platform these specific questions before committing:

1. What labs are included in the monthly fee, and which cost extra?
2. How often will I speak with a licensed clinician (not a health coach)?
3. Who is the prescribing physician, and are they licensed in my state?
4. What is the protocol if my hematocrit exceeds 54%?
5. Is there a cancellation policy, and do I own my lab results?

A useful way to think about this: treat the intake consultation the same way you would evaluate any specialist appointment. If the clinician cannot answer questions about secondary hypogonadism, fertility preservation, or cardiovascular monitoring, they are not equipped to manage TRT safely.

How AI-Assisted Symptom Screeners Are Changing Intake

Several newer telehealth platforms use validated questionnaires, such as the Androgen Deficiency in Aging Males (ADAM) questionnaire or the Aging Males' Symptoms (AMS) scale, as pre-consultation screening tools. The ADAM questionnaire has a sensitivity of approximately 88% for hypogonadism but a specificity of only 60%, meaning it generates a high false-positive rate when used alone [11]. These tools are appropriate for identifying who needs lab work, not for diagnosing or treating.

Platforms that present a high ADAM score as diagnostic confirmation before labs are drawn are misusing validated instruments. The questionnaire tells the physician whom to test, not whom to treat.

Putting It Together: A Step-by-Step Evaluation Checklist

Before signing up with any telehealth TRT platform, confirm all of the following:

Lab standards

• Two morning total testosterone draws required before prescribing
• Full hormone panel (LH, FSH, SHBG, estradiol, PSA, CBC) ordered at baseline
• Follow-up labs scheduled at 3 months and every 6 months thereafter

Clinical standards

• Prescribing clinician is a licensed MD, DO, NP, or PA in your state
• Intake consultation is at least 20 minutes with documented symptom review
• Cardiovascular history reviewed before prescribing
• Fertility goals discussed for men under 45

Safety standards

• Hematocrit monitoring protocol documented in writing
• PSA monitoring protocol for men 40 and older
• Clear dose-adjustment or hold criteria provided

Transparency

• Prescribing clinician is named and license-verifiable
• Pricing is itemized (consultation, labs, medication, follow-up)
• No mandatory supplement bundles
• Lab results are accessible to you directly

The Endocrine Society 2018 guideline summarizes the treatment goal this way: "The goal of testosterone therapy is to restore serum testosterone to the mid-normal range, improve symptoms, and minimize adverse effects." Any platform whose protocol does not align with that goal is not practicing evidence-based TRT.